Optometrists in Nicholasville, KY Accepting Medicare

8 Optometrists found. Showing 1 - 8

Dr. Clay S Mattson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1024 N Main St, Nicholasville, KY 40356 Phone: 859-881-5444    Fax: 859-881-3180

Ditto & Musick Optometrist Medicare: Medicare Enrolled Practice Location: 104 Fairfield Dr, Nicholasville, KY 40356 Phone: 859-887-2441    Fax: 859-885-3323

David P Ditto, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 104 Fairfield Dr, Nicholasville, KY 40356 Phone: 859-887-2441    Fax: 859-885-3323

Sight Savers Eye Care Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 181 E Brannon Road, Nicholasville, KY 40356 Phone: 859-971-2211    Fax: 859-971-2213

John E Musick, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 104 Fairfield Dr, Nicholasville, KY 40356 Phone: 859-887-2441    Fax: 859-885-3323

Bluegrass Family Vision Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 181 E Brannon Rd, Nicholasville, KY 40356 Phone: 859-971-2211

Mrs. Stacey Nichole Kroggel, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 104 Fairfield Dr, Nicholasville, KY 40356 Phone: 859-887-2441    Fax: 859-885-3323

Steven Christopher Mayes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 181 E Brannon Rd, Nicholasville, KY 40356 Phone: 859-971-2211    Fax: 859-971-2213

News Archive

Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals

Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

Discovery Labs provides expanded update on efforts to gain FDA marketing authorization for Surfaxin in RDS

Discovery Laboratories, Inc. is providing an expanded update regarding ongoing efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization for Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

Compirion Healthcare Solutions webinar for improving hospital emergency department standards

A webinar on JCAHO Emergency Department Core Measures: Achieving Successful Quality Outcomes is being presented by Compirion Healthcare Solutions to aid Hospital Emergency Departments in instituting treatment standards as defined by the Joint Commission, for AMI, CHA and CAP patients. Compliance with JCAHO Core Measures produces better outcomes for the patient while assuring maximum MSI reimbursement to the hospital.

FDA, EMA approve Repligen's proposal for Phase 3 re-read in RG1068 trial for pancreatic imaging

Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).

Read more Medical News

› Verified 8 days ago